Patents by Inventor Qide Li

Qide Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT USE OF PYRROLOPYRIMIDINE COMPOUND, AND SOLID PHARMACEUTICAL COMPOSITION OF PYRROLOPYRIMIDINE COMPOUND
    Publication number: 20220072002
    Abstract: A treatment use of a pyrrolopyrimidine compound, and a solid pharmaceutical composition of a pyrrolopyrimidine compound. In particular, the present invention relates to a pyrrolopyrimidine compound or a pharmaceutical composition thereof for treating myeloproliferative neoplasms, and a method therefor or a use thereof.
    Type: Application
    Filed: December 24, 2019
    Publication date: March 10, 2022
    Applicant: CHIA TAI TIANQING PHARMACEUTICALGROUP CO., LTD.
    Inventors: Dong WANG, Qingxia LI, Jun DAI, Chen LI, Zhulian JIANG, Yanqing SUN, Jingjing CHEN, Lingling JIN, Jundong LIU, Qide LI
  • Crystalline forms of tenofovir dipivoxil fumarate
    Patent number: 9187508
    Abstract: The present invention relates to a crystalline form of tenofovir dipivoxil fumarate, a crystalline composition and a pharmaceutical composition comprising the crystalline form, and also to a process for preparing the same and the use for prophylaxis or treatment of a disease associated with a viral infection. The crystalline form has an X-ray powder diffraction pattern using Cu-K? radiation, expressed in terms of lattice spacing “d” comprising peaks at about 18.4714 ?, 5.0350 ?, 4.6380 ?, 4.5347 ?, 4.3838 ?, 4.2874 ? and 3.6304 ?.
    Type: Grant
    Filed: August 1, 2011
    Date of Patent: November 17, 2015
    Assignee: Jiangsu Chiatai Tianqing Pharmaceutical Co., LTD.
    Inventors: Aiming Zhang, Qide Li, Chunguang Xia, Xiquan Zhang
  • Crystalline Forms of Tenofovir Dipivoxil Fumarate
    Publication number: 20130324498
    Abstract: The present invention relates to a crystalline form of tenofovir dipivoxil fumarate, a crystalline composition and a pharmaceutical composition comprising the crystalline form, and also to a process for preparing the same and the use for prophylaxis or treatment of a disease associated with a viral infection. The crystalline form has an X-ray powder diffraction pattern using Cu-K? radiation, expressed in terms of lattice spacing “d” comprising peaks at about 18.4714 ?, 5.0350 ?, 4.6380 ?, 4.5347 ?, 4.3838 ?, 4.2874 ? and 3.6304 ?.
    Type: Application
    Filed: August 1, 2011
    Publication date: December 5, 2013
    Applicant: Jiangsu Chiatai Tianqing Pharmaceutical Co., Ltd
    Inventors: Aming Zhang, Qide Li, Chunguang Xia, Xiquan Zhang